Prolonged exposure therapy + MIDOMAFETAMINE for alcoholism

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Feb 2023: Trial registered, NCT05709353
  2. 19 Sep 2023: Trial started, NCT05709353

The trials

NCT05709353: MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder

State
State not given
Phase
Phase 2
People
120 planned
Started
19 Sep 2023
Primary completion
May 2026
Arms
COPE + MDMA
Results
None posted
  1. 2 Feb 2023: Trial registered
  2. 19 Sep 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.